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In the previous issue of Critical Care, a new study reports 
that elevated pulmonary dead space is superior to 
measures of oxygenation (arterial partial pressure of 
oxygen/fraction of inspired oxygen, or PaO2/FiO2) for 
predicting physiologic and clinical responses to the prone 
position in patients with severe acute respiratory distress 
syndrome (ARDS) (PaO2/FiO2 of less than 100 mm Hg) 
[1]. In addition, the authors found that a decrease in 
arterial partial pressure of carbon dioxide (PaCO2) was 
superior to indices of oxygenation as a method for 
identifying responders to prone positioning. Also, the 
authors reported that a recently proposed method to 
estimate physiologic dead space did not have the same 
prognostic value as a direct measurement of physiologic 
dead space [2].
For many years, arterial hypoxemia was considered to 
be the primary physiologic abnormality that charac-
terized the gas-exchange impairment in critically ill 
patients with ARDS. As far back as 1975, the inter-
relationship between lung recruitment and oxygenation 
with improvements in both lung compliance and alveolar 
dead space was elegantly demonstrated by Suter and 
colleagues [3]. Yet only in the past decade has there been 
a growing recognition that abnormalities in alveolar 
ventilation and carbon dioxide (CO2) excretion are 
equally important in contributing to the pulmonary 
physiologic abnormalities in patients with ARDS. A pros-
pective study of 179 patients in whom pulmonary dead 
space was measured within 24 hours of ARDS onset 
indicated that dead space was markedly elevated in the 
early phase of ARDS and was associated with higher 
mortality [4]. Subsequent work has confi rmed that an 
elevated pulmonary dead space frequently occurs in the 
early phase of ARDS and has prognostic value [5-8].
Th e results of the current study are important because 
they demonstrate the potential value of directly 
measuring pulmonary dead space as a physiologic end-
point in patients being treated with a new therapeutic 
modality (in this case, prone positioning). Th e value of 
measuring pulmonary dead space also was reported in a 
recent clinical trial of activated protein C in patients with 
non-septic acute lung injury [9]. In addition, the current 
study found that changes in pulmonary dead space did 
not correlate well with indices of oxygenation and 
actually correlated better in an inverse relationship to 
quasi-static respiratory compliance. Th is result matches 
well with a prior study in which measurement of 
oxygenation by PaO2/FiO2 in patients with ARDS had less 
prognostic value for mortality than a direct measurement 
of the pulmonary dead space [4].
Traditionally, determining how eff ective prone 
position ing is and, in turn, whether this therapy should 
be continued has been judged by improvements in 
oxygenation [10]. However, prone positioning may 
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A study published in the previous issue of Critical Care 
demonstrates that measurement of the pulmonary 
dead-space fraction is superior to hypoxemia as an 
indicator of a favorable physiologic response to prone 
positioning in patients with severe acute respiratory 
distress syndrome. These results add to the growing 
evidence supporting the clinical and research value 
of measuring pulmonary dead space in patients with 
acute respiratory distress syndrome and using this 
pulmonary physiologic end-point as one indicator of a 
favorable response to therapy.
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improve mortality in the subset of patients with severe 
ARDS [11], so that using the most sensitive test for 
detecting a positive response assumes greater 
importance. ARDS is a hetero geneous disease containing 
lung compartments in which the time course for 
complete recruitment may take hours [12]. In the current 
study, maximal improvements in dead-space ventilation 
tended to occur earlier (3 hours) compared with maximal 
improvements in oxygenation (15  hours). Th erefore, 
measuring dead space appears to be a particularly 
expedient way to assess the potential eff ectiveness of 
prone positioning. Th at improvement in pulmonary dead 
space is a more sensitive indicator of lung recruitment 
may refl ect the fact that CO2 is much more diff usible 
across tissue membranes than oxygen [13], so that even 
small improvements in aeration from early recruitment 
of perfused alveoli are more likely to produce a detectable 
signal.
Th e current study also demonstrated that estimates of 
dead space using a recently proposed method [2] 
signifi cantly underestimated actual measured pulmonary 
dead space. We are not surprised by this fi nding, because 
the gold standard for dead-space measurements requires 
that arterial blood gas sampling occur simultaneously 
with the mixed expired CO2 sampling. Th is standard was 
lacking in the validation study by Siddiki and colleagues 
[2]. We have found that, even over relatively brief periods 
of time, the mixed expired CO2 can fl uctuate by 3 to 
9 mm Hg, which could introduce a measurement error of 
between 10% and 20%.
Th ere are some limitations to the current study, most 
importantly the small number of patients (n  =  13) who 
were included. Also, the study was focused only on 
patients with very severe ARDS (PaO2/FiO2 of less than 
100  mm  Hg), although this is a group for whom rescue 
therapies and physiologic evaluations are important [14]. 
However, the results of the current study match well with 
a prior study in which a decline in PaCO2 was of greater 
prognostic value in prone-position therapy for acute lung 
injury than indices of oxygenation [15]. In conclusion, the 
current study adds to the growing evidence that supports 
the clinical and research value of measuring pulmonary 
dead space in patients with ARDS and using this 
pulmonary physiologic end-point as one indicator of 
response to therapy.
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